CTI BioPharma Corp (NASDAQ:CTIC) Investor Alert: Investigation over Potential Wrongdoing
An investigation on behalf of current long-term investors in shares CTI BioPharma Corp (NASDAQ:CTIC) shares was announced over potential breaches of fiduciary duties by certain officers and directors at CTI BioPharma, formerly Cell Therapeutics.
View full press release